Tetra Pharm Technologies
Pharmaceutical drugs targeting the central nervous system (CNS) and the immune system.
Tetra Pharm Technologies is a Danish biotech company founded in 2018 by Martin Rose and Jesper Breum, both of whom have held senior positions in several global pharmaceutical companies.
The company specializes in the development of pharmaceutical drugs targeting the central nervous system (CNS) and the immune system, with the aim of treating and improving the quality of life for patients with neurological diseases and mental disorders. Their innovative approach leverages the endocannabinoid system (ECS) to create new treatment options for conditions with currently limited solutions.
With a strong research and development pipeline and a dedicated team, Tetra Pharm Technologies is an emerging force in the pharmaceutical industry, striving to make groundbreaking advancements in the treatment of complex neurological and mental health disorders.
See other Investments
Drone-based and automated repair of leading-edge erosion on wind turbine blades.
Industry
Green energyFounded
2020Location
Mørke
Investment models designed to seamlessly integrate with companies’ sustainability strategies.
Industry
FinanceFounded
2019Location
Bagsværd
Import and distribution of exclusive luxury vehicles.
Industry
WholesaleFounded
2023Location
Kvistgård
Contact Us
We welcome inquiries whether you want to learn more about Thorsen Group, pitch a new business idea, or have a request related to our portfolio companies. Send an email to kontakt@thorsengroup.dk, and we will get back to you as soon as possible.
Pitch Your Idea
You are always welcome to reach out and pitch a new business idea. Send us an email at kontakt@thorsengroup.dk.